Victor W Wong1, Bill Beasley2, John Zepeda2, Reinhold H Dauskardt3, Paul G Yock4, Michael T Longaker1, Geoffrey C Gurtner1. 1. Department of Surgery, Stanford University , Stanford, California. 2. Neodyne Biosciences, Inc. , Menlo Park, California. 3. Department of Materials Science and Engineering, Stanford University , Stanford, California. 4. Department of Biomedical Engineering, Stanford University , Stanford, California.
Abstract
OBJECTIVE: To mechanically control the wound environment and prevent cutaneous scar formation. APPROACH: We subjected various material substrates to biomechanical testing to investigate their ability to modulate skin behavior. Combinations of elastomeric materials, adhesives, and strain applicators were evaluated to develop topical stress-shielding devices. Noninvasive imaging modalities were utilized to characterize anatomic site-specific differences in skin biomechanical properties in humans. The devices were tested in a validated large animal model of hypertrophic scarring. Phase I within-patient controlled clinical trials were conducted to confirm their safety and efficacy in scar reduction in patients undergoing abdominoplasty surgery. RESULTS: Among the tested materials and device applicators, a polymer device was developed that effectively off-loaded high tension wounds and blocked pro-fibrotic pathways and excess scar formation in red Duroc swine. In humans, different anatomic sites exhibit unique biomechanical properties that may correlate with the propensity to form scars. In the clinical trial, utilization of this device significantly reduced incisional scar formation and improved scar appearance for up to 12 months compared with control incisions that underwent routine postoperative care. INNOVATION: This is the first device that is able to precisely control the mechanical environment of incisional wounds and has been demonstrated in multiple clinical trials to significantly reduce scar formation after surgery. CONCLUSION: Mechanomodulatory strategies to control the incisional wound environment can significantly reduce pathologic scarring and fibrosis after surgery.
OBJECTIVE: To mechanically control the wound environment and prevent cutaneous scar formation. APPROACH: We subjected various material substrates to biomechanical testing to investigate their ability to modulate skin behavior. Combinations of elastomeric materials, adhesives, and strain applicators were evaluated to develop topical stress-shielding devices. Noninvasive imaging modalities were utilized to characterize anatomic site-specific differences in skin biomechanical properties in humans. The devices were tested in a validated large animal model of hypertrophic scarring. Phase I within-patient controlled clinical trials were conducted to confirm their safety and efficacy in scar reduction in patients undergoing abdominoplasty surgery. RESULTS: Among the tested materials and device applicators, a polymer device was developed that effectively off-loaded high tension wounds and blocked pro-fibrotic pathways and excess scar formation in red Duroc swine. In humans, different anatomic sites exhibit unique biomechanical properties that may correlate with the propensity to form scars. In the clinical trial, utilization of this device significantly reduced incisional scar formation and improved scar appearance for up to 12 months compared with control incisions that underwent routine postoperative care. INNOVATION: This is the first device that is able to precisely control the mechanical environment of incisional wounds and has been demonstrated in multiple clinical trials to significantly reduce scar formation after surgery. CONCLUSION: Mechanomodulatory strategies to control the incisional wound environment can significantly reduce pathologic scarring and fibrosis after surgery.
Authors: Thomas A Mustoe; Rodney D Cooter; Michael H Gold; F D Richard Hobbs; Albert-Adrien Ramelet; Peter G Shakespeare; Maurizio Stella; Luc Téot; Fiona M Wood; Ulrich E Ziegler Journal: Plast Reconstr Surg Date: 2002-08 Impact factor: 4.730
Authors: Victor W Wong; Kemal Levi; Satoshi Akaishi; Geoffrey Schultz; Reinhold H Dauskardt Journal: Plast Reconstr Surg Date: 2012-06 Impact factor: 4.730
Authors: Thomas G Weiser; Scott E Regenbogen; Katherine D Thompson; Alex B Haynes; Stuart R Lipsitz; William R Berry; Atul A Gawande Journal: Lancet Date: 2008-06-24 Impact factor: 79.321
Authors: Gregory S Schultz; Jeffrey M Davidson; Robert S Kirsner; Paul Bornstein; Ira M Herman Journal: Wound Repair Regen Date: 2011 Mar-Apr Impact factor: 3.617
Authors: David Lagares; Oscar Busnadiego; Rosa Ana García-Fernández; Mohit Kapoor; Shangxi Liu; David E Carter; David Abraham; Xu Shi-Wen; Patricia Carreira; Benjamin A Fontaine; Barry S Shea; Andrew M Tager; Andrew Leask; Santiago Lamas; Fernando Rodríguez-Pascual Journal: Arthritis Rheum Date: 2012-05
Authors: Scott D Varney; Courtney B Betts; Rui Zheng; Lei Wu; Boris Hinz; Jiliang Zhou; Livingston Van De Water Journal: J Cell Sci Date: 2016-01-12 Impact factor: 5.285
Authors: Leandra A Barnes; Clement D Marshall; Tripp Leavitt; Michael S Hu; Alessandra L Moore; Jennifer G Gonzalez; Michael T Longaker; Geoffrey C Gurtner Journal: Adv Wound Care (New Rochelle) Date: 2018-02-01 Impact factor: 4.730
Authors: Shamik Mascharak; Heather E desJardins-Park; Michael F Davitt; Nicholas J Guardino; Geoffrey C Gurtner; Derrick C Wan; Michael T Longaker Journal: Adv Wound Care (New Rochelle) Date: 2021-10-08 Impact factor: 4.947
Authors: A Alkhalil; S Tejiram; T E Travis; N J Prindeze; B C Carney; L T Moffatt; L S Johnson; J Ramella-Roman; J W Shupp Journal: Eplasty Date: 2015-07-02